CA Patent

CA2462112A1 — Spiro-hydantoin compounds useful as anti-inflammatory agents

Assigned to Cerep SA · Expires 2003-04-10 · 23y expired

What this patent protects

Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates,enantiomers, and diastereomers, and prodrugs thereof, (I) are useful as inhibitors of LFA-1/ICAM and as anti-inflammatory agents, wherein L and K are O or S; Z is N or CR4b; Ar is an optionally-sub…

USPTO Abstract

Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates,enantiomers, and diastereomers, and prodrugs thereof, (I) are useful as inhibitors of LFA-1/ICAM and as anti-inflammatory agents, wherein L and K are O or S; Z is N or CR4b; Ar is an optionally-substituted aryl or heteroaryl; G is a linker attached to T or M or is absent; J, M and T are selected to define a three to six membered saturated or partially unsaturated non-aromatic ring; and R2 ,R4a, R4b, and R4c are as defined in the specification.

Drugs covered by this patent

Patent Metadata

Patent number
CA2462112A1
Jurisdiction
CA
Classification
—
Expires
2003-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Cerep SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.